scorecard
  1. Home
  2. Science
  3. Health
  4. news
  5. Inside the 3-decade rise of Regeneron — How much taxpayers spent on hydroxychloroquine — Walgreens' $1 billion bet on primary care

Inside the 3-decade rise of Regeneron — How much taxpayers spent on hydroxychloroquine — Walgreens' $1 billion bet on primary care

Lydia Ramsey Pflanzer   

Inside the 3-decade rise of Regeneron — How much taxpayers spent on hydroxychloroquine — Walgreens' $1 billion bet on primary care

Hello,

Welcome to Dispensed Daily, your daily dose of healthcare news from Business Insider.

Are you new to the newsletter? Sign up here to get this email in your inbox every day.

A chart to start off your Thursday: Coronavirus hospitalizations are rising in the US after falling for 2 months. Health systems are at risk of being overwhelmed.

Inside Regeneron: How a 32-year-old biotech that fought Ebola and made its founders billionaires is leading the coronavirus-treatment race

Read the full story from Andrew Dunn here>>

Walgreens just made a $1 billion bet on bringing doctor's offices into its pharmacies, and it shows how the pharmacy giant is taking on CVS and Walmart as they beef up their health ambitions

Read more about the deal here>>

Trump's hydroxychloroquine obsession cost taxpayers at least $88 million

Read the full investigation from Kevin Dugan here>>

More stories we're reading:

Thoughts? Questions? You can find me at lramsey@businessinsider.com. Don't forget to subscribe to this daily email here. See you tomorrow for a longer, weekly recap version of Dispensed!

- Lydia

READ MORE ARTICLES ON



Popular Right Now



Advertisement